The DOI matches its Crossref record, with a small difference in title or year; 116 of the 120 references it cites were found in a registry or an index.
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association
Open accessAbstract
In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. We also propose revised stages of HF as: At risk for HF (Stage A), Pre‐HF (Stage B), Symptomatic HF (Stage C) and Advanced HF (Stage D). Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF). This includes HF with reduced ejection fraction (HFrEF): symptomatic HF with LVEF ≤40%; HF with mildly reduced ejection fraction (HFmrEF): symptomatic HF with LVEF 41–49%; HF with preserved ejection fraction (HFpEF): symptomatic HF with LVEF ≥50%; and HF with improved ejection fraction (HFimpEF): symptomatic HF with a baseline LVEF ≤40%, a ≥10 point increase from baseline LVEF, and a second measurement of LVEF > 40%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, a biomarker-based risk score including high-sensitivity cardiac troponin T ≥6 ng/L, NT-proBNP ≥125 pg/mL, high-sensitivity C-reactive protein ≥3 mg/L, and LV hypertrophy by ECG (with one point for each abnormal parameter) demonstrated good discrimination and calibration for predicting 5and 10-year HF risk among patients with diabetes.The highest 5-year risk of HF was noted among those”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [481]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citationVestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,487
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Self-citationDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Self-citationAngiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationCardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
Self-citationPitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Fourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K. A., Alpert, J. S., Jaffe, A. S., CHAITMAN, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018) · Circulation · doi:10.1161/cir.0000000000000617 · Cited by 4,037
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Self-citationYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Self-citationElliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Spironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908655 · Cited by 2,430
Self-citationThe progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · PubMed · Cited by 2,143
Pfeffer, M. A., Swedberg, K. B., Granger, C. B., Held, P., McMurray, J. J. V., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,895
Julian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Tamura, M. K., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,828
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,715
Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gregoratos, G., Jessup, M. L., et al. (2001) · Circulation · doi:10.1161/hc4901.102568 · Cited by 1,440
Vericiguat in patients with heart failure and reduced ejection fraction
Armstrong, P. W., Pieske, B., Anstrom, K. J., Ezekowitz, J., Hernandez, A. F., Butler, J., Lam, C. S. P., Ponikowski, P., Voors, A. A., Jia, G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915928 · Cited by 1,358
Self-citationPredicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
Pocock, S., Ariti, C. A., McMurray, J. J. V., Maggioni, A. P., Køber, L., Squire, I. B., Swedberg, K. B., Dobson, J., Poppe, K., WHALLEY, G. A., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs337 · Cited by 1,343
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C.-C., & Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.114.010637 · Cited by 1,157
Self-citationMartin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
SCAI clinical expert consensus statement on the classification of cardiogenic shock
Baran, D. A., Grines, C. L., Bailey, S. R., Burkhoff, D., Hall, S. A., Henry, T. D., Hollenberg, S. M., Kapur, N. K., O’Neill, W. W., Ornato, J. P., et al. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28329 · Cited by 1,019
Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.813 · Cited by 927
Self-citationBozkurt, B., Colvin, M. M., Cook, J., Cooper, L. T., Deswal, A. M., Fonarow, G. C., Francis, G. S., Lenihan, D. J., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 920
Self-citationBraunwald, E. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 862
Mueller, C. E., McDonald, K., de Boer, R. A., Maisel, A. S., Cleland, J. G. F., Kozhuharov, N., Coats, A. J. S., Metra, M., Mebazaa, A., Ruschitzka, F. T., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1494 · Cited by 850
Self-citationINTERMACS Profiles of Advanced Heart Failure: The Current Picture
Stevenson, L. W., Pagani, F. D., Young, J. B., Jessup, M. L., Miller, L. W., Kormos, R. L., Naftel, D. C., Ulisney, K. L., Desvigne-Nickens, P. M., & Kirklin, J. K. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.02.015 · Cited by 792
Gheorghiade, M., Zannad, F. M., Sopko, G. S., Klein, L., Piña, I. L., Konstam, M. A., Massie, B. M., Roland, E., Targum, S. L., Collins, S. P., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.590091 · Cited by 788
Self-citationSaunders, J. T., Nambi, V., de Lemos, J. A., Chambless, L. E., Virani, S. S., Boerwinkle, E., Hoogeveen, R. C., Liu, X., Astor, B. C., Mosley, T. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.005264 · Cited by 755
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., Solomon, S. D., Marler, J. R., Teerlink, J. R., Farb, A., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033502 · Cited by 750
Self-citationTsutsui, H., Isobe, M., Ito, H., Ito, H., Okumura, K., Ōno, M., Kitakaze, M., Kinugawa, K., Kihara, Y., Goto, Y., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0342 · Cited by 720
Self-citationdeFilippi, C. R., de Lemos, J. A., Christenson, R. H., Gottdiener, J. S., Kop, W. J., Zhan, M., & Seliger, S. L. (2010) · JAMA · doi:10.1001/jama.2010.1708 · Cited by 715
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Vaduganathan, M., Claggett, B. L., Jhund, P. S., Cunningham, J. W., Ferreira, J. P., Zannad, F. M., Packer, M., Fonarow, G. C., McMurray, J. J. V., & Solomon, S. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30748-0 · Cited by 681
Self-citationLedwidge, M., Gallagher, J., Conlon, C., Tallon, E., O’Connell, E., Dawkins, I., Watson, C., O’Hanlon, R., Bermingham, M., Patle, A., et al. (2013) · JAMA · doi:10.1001/jama.2013.7588 · Cited by 664
Cleland, J. G. F., Bunting, K. V., Flather, M. D., Altman, D. G., Holmes, J., Coats, A. J. S., Manzano, L., McMurray, J. J. V., Ruschitzka, F. T., van Veldhuisen, D. J., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx564 · Cited by 658
Self-citationHalliday, B. P., Wassall, R., Lota, A. S., Khalique, Z., Gregson, J., Newsome, S., Jackson, R. W., Rahneva, T., Wage, R., Smith, G. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32484-x · Cited by 657
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2025797 · Cited by 656
Self-citationChioncel, O., Mebazaa, A., Harjola, V., Coats, A. J. S., Piepoli, M. F., Crespo‐Leiro, M. G., Laroche, C., Seferovic, P. M., Anker, S. D., Ferrari, R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.890 · Cited by 597
Self-citationEpstein, F. H., & Katz, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220206 · Cited by 563
Bozkurt, B., Aguilar, D. A., Deswal, A. M., Dunbar, S. B., Francis, G. S., Horwich, T. B., Jessup, M. L., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000450 · Cited by 556
Self-citationSacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Solomon, S. D., Vaduganathan, M., L. Claggett, B., Packer, M., Zile, M., Swedberg, K., Rouleau, J., A. Pfeffer, M., Desai, A., H. Lund, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044586 · Cited by 551
Solomon, S. D., Claggett, B. L., Lewis, E. F., Desai, A. S., Anand, I. S., Sweitzer, N. K., O’Meara, E., Shah, S. J., McKinlay, S. M., Fleg, J. L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv464 · Cited by 538
Prevalence and Prognostic Significance of Heart Failure Stages
Ammar, K. A., Jacobsen, S. J., Mahoney, D. W., Kors, J. A., Redfield, M. M., Burnett, J. C. J., & Rodeheffer, R. J. (2007) · Circulation · doi:10.1161/circulationaha.106.666818 · Cited by 530
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Ávila, M. S., Ayub‐Ferreira, S. M., Wanderley, M. R. D. B., Cruz, F. D. D., Brandão, S. M. G., Rigaud, V. O. C., dos Santos, M. H. H., Hajjar, L. A., Filho, R. K., Hoff, P. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.049 · Cited by 510
Titration of medical therapy for heart failure with reduced ejection fraction
Greene, S. J., Fonarow, G. C., DeVore, A. D., Sharma, P. P., Vaduganathan, M., Albert, N. M., Duffy, C. I., Hill, C. L., McCague, K., Patterson, J. H., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.015 · Cited by 500
Self-citationMedical Management of Advanced Heart Failure
Nohria, A. (2002) · JAMA · doi:10.1001/jama.287.5.628 · Cited by 466
Atherton, J. J., Sindone, A. P., Pasquale, C. G. D., Driscoll, A. L., Macdonald, P. S., Hopper, I., Kistler, P. M., Briffa, T. G., Wong, J., Abhayaratna, W. P., et al. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1042 · Cited by 439
Self-citationLund, L. H., Claggett, B. L., Liu, J., Lam, C. S. P., Jhund, P. S., Rosano, G. M. C., Swedberg, K. B., Yusuf, S., Granger, C. B., Pfeffer, M. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1149 · Cited by 433
Self-citation(2015) · doi:10.1002/ejhf.289 · Cited by 417
Self-citationvan Veldhuisen, D. J., Linssen, G. C. M., Jaarsma, T., van Gilst, W. H., Hoes, A. W., Tijssen, J. G. P., Paulus, W. J., Voors, A. A., & Hillege, H. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.044 · Cited by 415
Hollenberg, S. M., Stevenson, L. W., Ahmad, T., Amin, V. J., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Peterson, P. N., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.001 · Cited by 344
Self-citationTsuji, K., Sakata, Y., Nochioka, K., Miura, M., Yamauchi, T., Onose, T., Abe, R., Oikawa, T., Kasahara, S., Sato, M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.807 · Cited by 337
Self-citationHeart Failure With Recovered Left Ventricular Ejection Fraction
Wilcox, J. E., Fang, J. C.-T., Margulies, K. B., & Mann, D. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.075 · Cited by 336
Lam, C. S. P., Gamble, G. D., Ling, L. H., Sim, D., Leong, K. T. G., Yeo, P. S. D., Ong, H. Y., Jaufeerally, F. R., Ng, T. P., Cameron, V. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy005 · Cited by 296
Self-citationVedin, O., Lam, C. S. P., Koh, A. S.-M., Benson, L., Teng, T. K., Tay, W. T., Braun, O. Ö., Savarese, G., Dahlström, U., & Lund, L. H. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.003875 · Cited by 290
Self-citationRoizen, M. F. (2012) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2012.01.067 · Cited by 272
Anker, S. D., Butler, J., Filippatos, G. S., Jamal, W., Salsali, A., Schnee, J. M., Kimura, K. A., Zeller, C., George, J. T., Brueckmann, M., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1596 · Cited by 250
Self-citationPellikka, P. A., She, L., Holly, T. A., Lin, G., Varadarajan, P., Pai, R. G., Bonow, R. O., Pohost, G. M., Panza, J. A., Berman, D. S., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1456 · Cited by 238
The MOGE(S) Classification of Cardiomyopathy for Clinicians
Arbustini, E., Narula, N., Tavazzi, L., Serio, A., Grasso, M., Favalli, V., Bellazzi, R., Tajik, J. A., Bonow, R. O., Fuster, V., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.027 · Cited by 222
ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure
Bonow, R. O., Ganiats, T. G., Beam, C. T., Blake, K., Casey, D. E., Goodlin, S. J., Grady, K. L., Hundley, R. F., Jessup, M. L., Lynn, T. E., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182507bec · Cited by 183
Gislason, G., Rasmussen, J. N., Abildstrom, S. Z., Schramm, T. K., Hansen, M. L., Buch, P., Sørensen, R., Folke, F., Gadsbøll, N., Rasmussen, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.669101 · Cited by 182
Temporal Trends in the Population Attributable Risk for Cardiovascular Disease
Cheng, S. C., Claggett, B. L., Correia, A. W., Shah, A. M., Gupta, D. K., Skali, H., Ni, H., Rosamond, W. D., HEISS, G. M., Folsom, A. R., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.008506 · Cited by 163
Berg, D. D., Wiviott, S. D., Scirica, B. M., Gurmu, Y., Mosenzon, O., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.042685 · Cited by 154
Zheng, S. L., Chan, F., Nabeebaccus, A., Shah, A. M., McDonagh, T. A., Okonko, D. O., & Ayis, S. A. (2017) · Heart · doi:10.1136/heartjnl-2017-311652 · Cited by 150
Outpatient Worsening Heart Failure as a Target for Therapy
Greene, S. J., Mentz, R. J., & Felker, G. M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5250 · Cited by 144
Rastogi, A., Novak, E. L., Platts, A. E., & Mann, D. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.879 · Cited by 140
Seid, M. A., Abdela, O. A., & Zeleke, E. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211768 · Cited by 128
Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation
Solomon, S. D., Claggett, B. L., Packer, M., Desai, A., Zile, M. R., Swedberg, K. B., Rouleau, J. L., Shi, V. C., Lefkowitz, M. P., & McMurray, J. J. V. (2016) · JACC Heart Failure · doi:10.1016/j.jchf.2016.05.002 · Cited by 111
Abraham, W. T., Psotka, M. A., Fiuzat, M., Filippatos, G. S., Lindenfeld, J. M., Mehran, R., Ambardekar, A. V., Carson, P. E., Jacob, R., Januzzi, J. L., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.10.002 · Cited by 108
Self-citationBozkurt, B., Hershberger, R. E., Butler, J., Grady, K. L., Heidenreich, P. A., Isler, M. L., Kirklin, J. K., & Weintraub, W. S. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000102 · Cited by 108
Self-citationHeart failure with preserved ejection fraction: controversies, challenges and future directions
Zakeri, R., & Cowie, M. (2018) · Heart · doi:10.1136/heartjnl-2016-310790 · Cited by 107
Comparison of Approaches for Heart Failure Case Identification From Electronic Health Record Data
Blecker, S., Katz, S. D., Horwitz, L. I., Kuperman, G. J., Park, H., Gold, A., & Sontag, D. A. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3236 · Cited by 97
The defintion of heart failure
Dénolin, H., Kuhn, H. J., Krayenbuehl, H. P., Loogen, F., & REALE, A. (1983) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061500 · Cited by 89
So many definitions of heart failure: are they all universally valid? A critical appraisal
Tan, L., Williams, S. G., Tan, D. K., & Solal, A. C. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.187 · Cited by 88
Risk Profiles in Heart Failure
Greene, S. J., Fonarow, G. C., & Butler, J. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007132 · Cited by 87
Self-citationNatriuretic Peptides as Inclusion Criteria in Clinical Trials
Ibrahim, N. E., Burnett, J. C. J., Butler, J., Camacho, A., Felker, G. M., Fiuzat, M., O’Connor, C. J., Solomon, S. D., Vaduganathan, M., Zile, M. R., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.12.010 · Cited by 83
Self-citationProgression of preclinical diastolic dysfunction to the development of symptoms
de, D. D. C., Hodge, D. O., Slusser, J. P., Redfield, M. M., Simari, R. D., Burnett, J. C., & Chen, H. (2010) · Heart · doi:10.1136/hrt.2009.177980 · Cited by 81
Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials
Butler, J., D, E. B. M., & Gheorghiade, M. (2014) · JAMA · doi:10.1001/jama.2014.6643 · Cited by 78
Self-citationSilent Disease Progression in Clinically Stable Heart Failure
Sabbah, H. N. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.705 · Cited by 76
The MELD-Plus: A generalizable prediction risk score in cirrhosis
Kartoun, U., Corey, K. E., Simon, T. G., Zheng, H., Aggarwal, R., Ng, K., & Shaw, S. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186301 · Cited by 75
Design of Therapy for Advanced Heart Failure
Stevenson, L. W. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.004 · Cited by 66
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Heidenreich, P. A., Fonarow, G. C., Breathett, K. K., Jurgens, C. Y., Pisani, B., Pozehl, B., Spertus, J. A., Taylor, K. G., Thibodeau, J. T., Yancy, C. W., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000099 · Cited by 61
Self-citationSymptom perception in heart failure: a scoping review on definition, factors and instruments
Santos, G. C., Liljeroos, M., Dwyer, A. A., Jaques, C., Girard, J., Strömberg, A., Hullin, R., & Schäfer‐Keller, P. (2019) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515119892797 · Cited by 60
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
Williams, D. M., & Evans, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00911-0 · Cited by 58
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure
Bozkurt, B., Hershberger, R. E., Butler, J., Grady, K. L., Heidenreich, P. A., Isler, M. L., Kirklin, J. K., & Weintraub, W. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.012 · Cited by 55
Self-citationPrevalence of Lactic Acidaemia in Patients with Advanced Heart Failure and Depressed Cardiac Output
Adamo, L., Nassif, M. E., Novak, E., LaRue, S., & Mann, D. L. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.628 · Cited by 53
Endpoints in Heart Failure Drug Development
Fiuzat, M., Lowy, N., Stockbridge, N., Sbolli, M., Latta, F., Lindenfeld, J., Lewis, E. F., Abraham, W. T., Teerlink, J. R., Walsh, M. N., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.12.011 · Cited by 53
Self-citationWagner, M., Tiffe, T., Morbach, C., Gelbrich, G., Störk, S., & Heuschmann, P. U. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316680693 · Cited by 49
Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure
Bozkurt, B. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.464 · Cited by 49
Self-citationMorbach, C., Gelbrich, G., Tiffe, T., Eichner, F. A., Christa, M., Mattern, R., Breunig, M., Cejka, V., Wagner, M., Heuschmann, P. U., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320922636 · Cited by 48
Linde, C. M., Curtis, A. B., Fonarow, G. C., Lee, K. L., Little, W. C., TANG, A. S. L., Levya, F., Momomura, S., Manrodt, C., Bergemann, T. L., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.023 · Cited by 33
Self-citationWagner, S. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630170075017 · Cited by 29
Heart failure. A proposed definition and classification
Wagner, S. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.5.675 · Cited by 25
Ejection fraction in heart failure revisited- where does the evidence start?
Böhm, M., Bewarder, Y., & Kindermann, I. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa281 · Cited by 22
Self-citationBozkurt, B., & Ezekowitz, J. A. (2020) · Circulation · doi:10.1161/circulationaha.120.045008 · Cited by 19
Self-citationPrevention or Procrastination for Heart Failure?
Cleland, J. G. F., Pellicori, P., & Clark, A. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.471 · Cited by 17
Disparities in Heart Failure Care
Pinney, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.008 · Cited by 11
The problem of defining heart failure
Harris, P. C. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877921 · Cited by 7
Progression of preclinical diastolic dysfunction to the development of symptoms
Chen, H. H., de Sa, D. C., Redfiled, M. M., & Burnett, J. C. J. (2008) · Heart Lung and Circulation · doi:10.1016/j.hlc.2007.11.024 · Cited by 4
Flagged first, then by citations
4 of the 120 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Young K, 2018, Preclinical heart failure: evaluation of long‐term outcomes in patients with stage A and stage B heart failure in the general population, Circulation, 134, A15193
Cited by
Sorted by citations
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Self-citationGlobal burden of heart failure: a comprehensive and updated review of epidemiology
Savarese, G., Becher, P. M., Lund, L. H., Seferovic, P. M., Rosano, G. M. C., & Coats, A. J. S. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac013 · Cited by 3,482
Self-citation2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,356
Self-citation
Metadata
- Authors
- Bozkurt, B., Coats, A. J. S., Tsutsui, H., Abdelhamid, C. M., Adamopoulos, S., Albert, N., Anker, S. D., Atherton, J., Böhm, M., Butler, J., Drazner, M. H., Michael Felker, G., Filippatos, G., Fiuzat, M., Fonarow, G. C., Gomez‐Mesa, J., Heidenreich, P., Imamura, T., Jankowska, E. A., Januzzi, J., Khazanie, P., Kinugawa, K., Lam, C. S. P., Matsue, Y., Metra, M., Ohtani, T., Francesco Piepoli, M., Ponikowski, P., Rosano, G. M. C., Sakata, Y., Seferović, P., Starling, R. C., Teerlink, J. R., Vardeny, O., Yamamoto, K., Yancy, C., Zhang, J., & Zieroth, S.
- Affiliations
- Tottori University (JP)
- Michael E. DeBakey VA Medical Center (US)
- Corresponding author
- Bozkurt, Biykem
- ORCID
- Bozkurt, Biykem
- Coats, Andrew J.S.
- Tsutsui, Hiroyuki
- Adamopoulos, Stamatis
- Albert, Nancy
- Anker, Stefan D.
- Atherton, John
- Böhm, Michael
- Butler, Javed
- Drazner, Mark H.
- Filippatos, Gerasimos
- Fiuzat, Mona
- Fonarow, Gregg C.
- Heidenreich, Paul
- Imamura, Teruhiko
- Jankowska, Ewa A.
- Januzzi, James
- Khazanie, Prateeti
- Kinugawa, Koichiro
- Lam, Carolyn S.P.
- Matsue, Yuya
- Metra, Marco
- Ohtani, Tomohito
- Ponikowski, Piotr
- Rosano, Giuseppe M.C.
- Sakata, Yasushi
- Starling, Randall C.
- Teerlink, John R.
- Vardeny, Orly
- Yamamoto, Kazuhiro
- Yancy, Clyde
- Zhang, Jian
- Zieroth, Shelley
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-03
- Volume
- 23
- Issue
- 3
- Pages
- 352-380
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W3132494856
- Cited by
- 1,665
- References
- 120
- Citations by year
- 2026: 278 · 2025: 389 · 2024: 351 · 2023: 286 · 2022: 257 · 2021: 101
- FWCI
- 166.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- heart failure, heart failure classification, heart failure staging, left ventricular ejection fraction, heart failure with reduced ejection fraction, natriuretic peptides, pulmonary congestion, systemic congestion
- MeSH terms
- Australia, Canada, Cardiology, China, Heart Failure, Humans, India, Japan, New Zealand, Prognosis, Stroke Volume, Writing, Ventricular Function, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
